Abiopharma

News list

📋 Yu-Hsin Lin (CEO, Chairman) plans to sell 127K shares of Belite Bio, Inc. (at $177.58 each, total $22.5M) Filed: Aug 12, 2026 | ID: 000825

Full text

News bot Aug. 12, 2026, 9:14 p.m.
📋 Form 144 Filing: Yu-Hsin Lin

Company: Belite Bio, Inc.

Filing Date: 2026-08-12

Relationship: CEO, Chairman
Planned Sale Details:
- Security: American Depositary Shares, each representing one ordinary share
- Shares to be Sold: 126,800
- Price per Share: $177.58
- Total Value: $22,517,144.00
- Planned Sale Date: 2026-08-12
- Broker: J.P. Morgan Securities LLC
- Exchange: NASDAQ
Additional Information:
- SEC File Number: 001-41359
- Issuer Contact Phone: 858-246-6240
- Issuer Address: 12750 High Bluff Drive, Suite 475, San Diego, CA, 92130
- Broker Address: 270 Park Avenue, 10th Floor, New York, NY, 10017
- Shares Outstanding: 39339960.0
- Number of Securities to be Sold: 7
- Signature: /s/ J.P. Morgan Securities LLC as agent and attorney-in-fact for Yu-Hsin Lin
- Plan Adoption Dates: 2025-12-23